Cargando…

In silico identification of novel lead compounds with AT(1 )receptor antagonist activity: successful application of chemical database screening protocol

BACKGROUND: AT(1 )receptor antagonists are clinically effective drugs for the treatment of hypertension, cardiovascular, and related disorders. In an attempt to identify new AT(1 )receptor antagonists, a pharmacophore-based virtual screening protocol was applied. The pharmacophore models were genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pal, Mahima, Paliwal, Sarvesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2012
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349973/ https://www.ncbi.nlm.nih.gov/pubmed/22380004 http://dx.doi.org/10.1186/2191-2858-2-7

Ejemplares similares

Identification of Novel HIV 1- Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening
por: Yadav, Divya, et al.
Publicado: (2012)

In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
por: Sankar, Muthumanickam, et al.
Publicado: (2021)

Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies
por: Sharma, Mukta, et al.
Publicado: (2020)

In Silico Identification of Tripeptides as Lead Compounds for the Design of KOR Ligands
por: Stefanucci, Azzurra, et al.
Publicado: (2021)

Gastroprotective activity of reconstituted red fruit pulp concentrate of Citrullus lanatus in rats
por: Sharma, Swapnil, et al.
Publicado: (2014)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

Phytochemical evaluation and anti-hemorrhoidal activity of bark of Acacia ferruginea DC
por: Faujdar, Samriti, et al.
Publicado: (2018)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)

In Silico Screening and Analysis of Broad-Spectrum Molecular Targets and Lead Compounds for Diarrhea Therapy
por: Ugboko, Harriet U, et al.
Publicado: (2019)

Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database
por: Wang, Jing, et al.
Publicado: (2016)

Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening
por: Li, Binjie, et al.
Publicado: (2023)

Corrigendum: In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)

First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic Compounds
por: Gallinger, Tom L., et al.
Publicado: (2022)

Protocol for hit-to-lead optimization of compounds by auto in silico ligand directing evolution (AILDE) approach
por: Mei, Longcan, et al.
Publicado: (2021)

Identification of anti-cyanobacterial leads targeting carbonic anhydrase from phytochemical database using in silico approach
por: Padhiary, Archana, et al.
Publicado: (2023)

In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein
por: Mathew, Shilu, et al.
Publicado: (2021)

In-Silico Identification of Natural Compounds from Traditional Medicine as Potential Drug Leads against SARS-CoV-2 Through Virtual Screening
por: Mithilesh, Sai, et al.
Publicado: (2022)

Antimicrobial activity of methanolic extracts of Vernonia cinerea against Xanthomonas oryzae and identification of their compounds using in silico techniques
por: Joshi, Tushar, et al.
Publicado: (2021)

In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
por: Ghufran, Mehreen, et al.
Publicado: (2023)

Privacy-preserving search for chemical compound databases
por: Shimizu, Kana, et al.
Publicado: (2015)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database
por: Revol, Bruno, et al.
Publicado: (2022)

N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies
por: Tripathi, Avinash C., et al.
Publicado: (2018)

Virtual Screening of a Marine Natural Product Database for In Silico Identification of a Potential Acetylcholinesterase Inhibitor
por: Gade, Anushree Chandrashekhar, et al.
Publicado: (2023)

In vivo and in silico screening for antimicrobial compounds from cyanobacteria
por: Strieth, Dorina, et al.
Publicado: (2022)

In Silico Identification of Lead Compounds for Pseudomonas Aeruginosa PqsA Enzyme: Computational Study to Block Biofilm Formation
por: Shahab, Muhammad, et al.
Publicado: (2023)

Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species
por: Maruca, Annalisa, et al.
Publicado: (2017)

How can Databases assist with the Prediction of Chemical Compounds?
por: Schön, J Christian
Publicado: (2014)

Statistical-based database fingerprint: chemical space dependent representation of compound databases
por: Sánchez-Cruz, Norberto, et al.
Publicado: (2018)

Insights into ultrasound-promoted degradation of naphthenic acid compounds in oil sands process affected water. Part II: In silico quantum screening of hydroxyl radical initiated and propagated degradation of benzoic acid
por: Kirpalani, Deepak M., et al.
Publicado: (2022)

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
por: Haga, Shiori, et al.
Publicado: (2010)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease
por: Satarker, Sairaj, et al.
Publicado: (2021)

In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
por: Shahanshah, Mohd Fardeen Husain, et al.
Publicado: (2022)

In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2
por: Trezza, Alfonso, et al.
Publicado: (2022)

Neglected Disease – African Sleeping Sickness: Recent Synthetic and Modeling Advances
por: Paliwal, Sarvesh K., et al.
Publicado: (2011)

TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
por: Chen, Calvin Yu-Chian
Publicado: (2011)

PeruNPDB: the Peruvian Natural Products Database for in silico drug screening
por: Barazorda-Ccahuana, Haruna L., et al.
Publicado: (2023)

From compound to target: chemical proteomics and in silico screening identify Hsp90 and CDPK2 as putative targets in Plasmodium falciparum
por: Lauciello, Leonardo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m3d4456k65h12e7c234ulqdhov